Skip to main content

Table 4 Crude means (standard deviation) and estimated changes from baseline (∆) for inflammatory markers

From: Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study

 

8 week

(Control = 19 Intervention =21)

Mean (DP)

a

p a

Tumor necrosis factor-α (pg/dL)

 Control

84.5 (51.2)

+19.4

 

 Intervention

90.7 (48.8)

+27.2

0.58

Interleukin-4 (pg/dL)

 Control

21.5 (9.7)

−0.8

 

 Intervention

20.7 (6.7)

−1.5

0.67

Interleukin-6 (pg/dL)

 Control

67.3 (80.2)

−228.1

 

 Intervention

61.5 (54.3)

−85.3

0.45

Interleukin-8 (pg/dL)

 Control

64.7 (48.4)

−11.3

 

 Intervention

53.6 (12.4)

−3.3

0.47

Interleukin-10 (pg/dL)

 Control

53.8 (7.1)

−35.7

 

 Intervention

56.3 (8.3)

−10.6

0.01

Interleukin-33 (pg/dL)

 Control

70.4 (15.6)

−5.2

 

 Intervention

69.4 (17.0)

−5.5

0.97

Interleukin-1b (pg/dL)

 Control

18.0 (3.4)

−2.3

 

 Intervention

17.9 (3.4)

−0.6

0.24

Interleukin-17a (pg/dL)

 Control

3649.2 (4254.2)

+951.5

 

 Intervention

6130.0 (7644.2)

+3621.7

0.24

Interferon-γ (pg/dL)

 Control

82.6 (112.3)

+9.3

 

 Intervention

53.2 (100.7)

+7.1

0.90

  1. aLinear mixed models include time, treatment and time x treatment interaction, adjusted for baseline values